ArticleBMC psychiatry2025
Interpretable machine learning for classification and risk factor identification of anxiety, depression, and insomnia symptoms after the full opening of China's COVID-19 lockdown.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of health anxiety trajectories in rabies exposure patients based on machine learning.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental health disorders remain a critical global public health issue, exacerbated by the coronavirus disease 2019 (COVID-19) pandemic. Post-lockdown mental health assessments are scarce. This study aims to develop interpretable machine learning (ML) models to classify and identify key risk factors for anxiety, depression, and insomnia symptoms in mainland China after the opening of COVID-19 lockdown.
methodsCross-sectional data collected in 2023 and 2024 were used as the training set (with test set divided in a 7:3 ratio) and internal validation set, respectively. The Generalized Anxiety Disorder-7 (GAD-7) scale, Patient Health Questionnaire-9 (PHQ-9) scale, and Insomnia Severity Index (ISI) scale were employed to assess symptoms of anxiety, depression, and insomnia, respectively. Seven interpretable machine learning models incorporating 27 relevant influencing factors were applied for the classification and risk factor identification of three mental health symptoms.
resultsThe survey included 65,292 respondents with 36,996 cases in the training set (with test set) and 28,296 cases in the external validation set. The Categorical Boosting (CatBoost) model achieved the highest Area Under the Curve (AUC) value among seven ML models, with 0.817, 0.829, and 0.819 for anxiety, depression, and insomnia symptoms in the test set, and with 0.815, 0.820, and 0.822 for anxiety, depression, and insomnia symptoms in the external validation set. Several factors associated with a lower prevalence of anxiety symptom, including satisfactory neighborhood relationship, extensive knowledge about COVID-19, maintaining a regular sleep-wake cycle, daily vegetable consumption, and sufficient time spent sunbathing. Conversely, factors associated with a higher prevalence comprised history of anxiety, history of insomnia, history of depression, external noise at home, and fear of COVID-19 infection. Similar results were observed for depression and insomnia symptoms.
conclusionsThe explainable ML model found that healthy habits and positive social ties were linked to lower anxiety, depression, and insomnia symptoms. In contrast, past mental health issues and stressors were tied to higher levels. Public health efforts should focus on encouraging these modifiable habits and strengthening community support, to help improve residents' mental health, especially in the aftermath of a pandemic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.